Cochrane Abstracts
Direct thrombin inhibitors and factor Xa inhibitors for acute coronary syndromes: a network meta‐analysis
There's more to see -- the rest of this topic is available only to subscribers.
Citation
"Direct Thrombin Inhibitors and Factor Xa Inhibitors for Acute Coronary Syndromes: a Network Meta‐analysis." Cochrane Abstracts, John Wiley & Sons, Inc, 2026. Evidence Central, evidence.unboundmedicine.com/evidence/view/Cochrane/439286/all/Direct_thrombin_inhibitors_and_factor_Xa_inhibitors_for_acute_coronary_syndromes:_a_network_meta‐analysis.
Direct thrombin inhibitors and factor Xa inhibitors for acute coronary syndromes: a network meta‐analysis. Cochrane Abstracts. John Wiley & Sons, Inc; 2026. https://evidence.unboundmedicine.com/evidence/view/Cochrane/439286/all/Direct_thrombin_inhibitors_and_factor_Xa_inhibitors_for_acute_coronary_syndromes:_a_network_meta‐analysis. Accessed February 11, 2026.
Direct thrombin inhibitors and factor Xa inhibitors for acute coronary syndromes: a network meta‐analysis. (2026). In Cochrane Abstracts. John Wiley & Sons, Inc. https://evidence.unboundmedicine.com/evidence/view/Cochrane/439286/all/Direct_thrombin_inhibitors_and_factor_Xa_inhibitors_for_acute_coronary_syndromes:_a_network_meta‐analysis
Direct Thrombin Inhibitors and Factor Xa Inhibitors for Acute Coronary Syndromes: a Network Meta‐analysis [Internet]. In: Cochrane Abstracts. John Wiley & Sons, Inc; 2026. [cited 2026 February 11]. Available from: https://evidence.unboundmedicine.com/evidence/view/Cochrane/439286/all/Direct_thrombin_inhibitors_and_factor_Xa_inhibitors_for_acute_coronary_syndromes:_a_network_meta‐analysis.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - Direct thrombin inhibitors and factor Xa inhibitors for acute coronary syndromes: a network meta‐analysis
ID - 439286
BT - Cochrane Abstracts
UR - https://evidence.unboundmedicine.com/evidence/view/Cochrane/439286/all/Direct_thrombin_inhibitors_and_factor_Xa_inhibitors_for_acute_coronary_syndromes:_a_network_meta‐analysis
PB - John Wiley & Sons, Inc
DB - Evidence Central
DP - Unbound Medicine
ER -
